Subscribe To
ARGX / argenx SE: Again Following Dutch Biotech, Prior Recommendation Near-Term Gain
ARGX News
By GlobeNewsWire
November 1, 2023
argenx to Present at Upcoming Investor Conferences
November 1, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peop more_horizontal
By Seeking Alpha
October 31, 2023
argenx SE (ARGX) Q3 2023 Earnings Call Transcript
argenx SE (NASDAQ:ARGX ) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET Company Participants Beth DelGiacco - VP and Global Head, Corpor more_horizontal
By GlobeNewsWire
October 24, 2023
argenx to Report Third Quarter 2023 Financial Results and Business Update on October 31, 2023
October 24, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peop more_horizontal
By Seeking Alpha
October 17, 2023
argenx: Efgartigimod Is Not Just A Drug, A Cornerstone
argenx exhibits robust financials with a Q2 YoY net sales surge to $269.3M and liquidity of $2.0B but faces increasing operating costs and R&D expendi more_horizontal
By MarketBeat
September 25, 2023
Argenx's 28% Surge & Promising Product Propel Investor Confidence
The stock gapped up nearly 28% on July 17, after announcing better-than-expected results from a clinical trial of its treatment for patients suffering more_horizontal
By GlobeNewsWire
August 30, 2023
argenx to Present at Upcoming Investor Conferences
August 30 , 202 3 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of pe more_horizontal
By The Motley Fool
July 21, 2023
Why Shares of Argenx Jumped This Week
Argenx has only two approved therapies, Vyvgart and Vyvgart Hytrulo. Vyvgart Hytrulo fared well in a trial to treat adults with chronic inflammatory d more_horizontal
By GlobeNewsWire
July 20, 2023
argenx to Report Half Year 2023 Financial Results and Second Quarter Business Update on July 27, 2023
July 20 , 202 3 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peop more_horizontal